Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
One of the most effective medications used for various cardiac diseases and syndromes to improve symptoms and, in some cases, prognosis, are betablockers (BBs) and calcium channel blockers (CCBs). The combination of BBs and dihydropyridine CCBs has a synergistic clinical effect and is well tolerated...
Saved in:
| Main Authors: | S. S. Yakushin, K. G. Pereverzeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2024-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5562 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
by: K. Makarounas-Kirchmann, et al.
Published: (2010-12-01) -
A Modern View on the Treatment for Acute Calcium Channel Blocker Poisoning
by: A. Yu. Simonova, et al.
Published: (2024-09-01) -
Design and synthesis of novel 4-substituted 1,4-dihydropyridine derivatives as hypotensive agents
by: Prasanna A. Datar, et al.
Published: (2016-09-01) -
Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study
by: Tamara Theiner, et al.
Published: (2024-12-01) -
Efficacy of insulin therapy in severe poisoning with calcium channel blockers
by: A. Yu. Simonova, et al.
Published: (2023-12-01)